Search all trials

Find therapies in clinical trials near you – page 15

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Coronary artery disease

Not recruiting

Registered drug

Study on Inclisiran and Statin Therapy for Patients with Non-obstructive Coronary Artery Disease to Assess Atherosclerotic Plaque Progression

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Atorvastatin

Contact Research Centre

Thrombotic thrombocytopenic purpura

Not recruiting

Registered drugNo placebo

Study on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Caplacizumab

Contact Research Centre

Breast cancer+1

Not recruiting

Registered drugNo placebo

Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Atrial fibrillation+2

Not recruiting

Registered drug

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Apixaban

Contact Research Centre

Diffuse large B-cell lymphoma+1

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Odronextamab Compared to Standard Treatment in Adults with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Follicular lymphoma+2

Not recruiting

Registered drugNo placebo

Study Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Diffuse large B-cell lymphoma refractory

Not recruiting

Registered drug

Study on Brentuximab Vedotin, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Brentuximab Vedotin

Contact Research Centre

Crohn's disease

Not recruiting

Investigational

Study on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Upadacitinib

Contact Research Centre

Endometrial cancer+6

Not recruiting

Registered drugNo placebo

Study on Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Liver, Colon, Pancreatic, Bile Duct, Gallbladder, Endometrial, or Esophageal Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Belzutifan

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drug

Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Doxorubicin

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Tuvusertib and Cemiplimab for Patients with Non-Squamous Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Colorectal cancer metastatic

Not recruiting

Registered drugNo placebo

Study of Adagrasib and Cetuximab for Patients with Advanced Colorectal Cancer with KRAS G12C Mutation After First-Line Therapy

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Adagrasib

Contact Research Centre

Find therapies in clinical trials near you – page 15

192 trials match your criteria

Coronary artery disease

Study on Inclisiran and Statin Therapy for Patients with Non-obstructive Coronary Artery Disease to Assess Atherosclerotic Plaque Progression

Thrombotic thrombocytopenic purpura

Study on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura

Breast cancer+1

Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Atrial fibrillation+2

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Diffuse large B-cell lymphoma+1

Study on the Effectiveness and Safety of Odronextamab Compared to Standard Treatment in Adults with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

Follicular lymphoma+2

Study Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma

Diffuse large B-cell lymphoma refractory

Study on Brentuximab Vedotin, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma

Crohn's disease

Study on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease

Endometrial cancer+6

Study on Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Liver, Colon, Pancreatic, Bile Duct, Gallbladder, Endometrial, or Esophageal Cancer

Hormone receptor positive HER2 negative breast cancer

Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients

Non-small cell lung cancer

Study of Tuvusertib and Cemiplimab for Patients with Non-Squamous Non-Small Cell Lung Cancer After Previous Treatments

Colorectal cancer metastatic

Study of Adagrasib and Cetuximab for Patients with Advanced Colorectal Cancer with KRAS G12C Mutation After First-Line Therapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.